Belize vs China: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Belize
0.1%
in 2024
China
0.1%
in 2024
Belize rank
112th
China rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Belize
- China
How they compare
Belize currently reports 0.1% against 0.1% in China, a difference of 0.0%.
Across all 10 years both countries report, China has been ahead every year.
Belize ranks 112th and China ranks 112th of 215 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belize | China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.2% | 0.1% | China |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Belize or China?
- Belize, at 0.1% against 0.1% in China as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Belize and China?
- 0.0%, with Belize ahead.
- How many years of comparable data are there for Belize and China?
- 10 years are reported by both, from 2015 to 2024.
- How do Belize and China rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Belize ranks 112th and China ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.